Gene editing: Is era of designer humans getting closer?
By Fergus Walsh,
BBC
| 12. 03. 2015
[cites CGS' Marcy Darnovsky]
An international meeting of leading scientists has said it would be "irresponsible" to allow the creation of genetically altered humans.
But they said basic research involving embryo gene editing should continue in order to improve understanding of human biology.
As scientific knowledge advances and societal views evolve, they added, the clinical use of genetically modified embryos should be revisited on a "regular basis".
The gene editing summit in Washington was organised to discuss new techniques which enable researchers to alter human DNA.
Genetic enhancement has been a favourite theme for science fiction writers. The film Gattaca imagined a world where children were conceived through gene manipulation.
A Brave New World of designer humans - although still a long way off - has moved a step closer as a result new gene editing techniques.
Three years ago scientists invented a new simple cut-and-paste system, called CRISPR-Cas9, for editing DNA.
Scientists across the world immediately adopted this rapid, cheap and accessible tool in order to speed up their research.
For patients with blood, immune, muscle or skin disorders it offers the hope...
Related Articles
By Jason Liebowitz, The New Yorker | 03.06.2026
When Talaya Reid was in high school, in a quiet suburb of Philadelphia, she developed fatigue so severe that she spent afternoons napping instead of going out with friends. She was lethargic at school and her grades suffered, but after...
By Émile P. Torres, Truthdig | 02.26.2026
It’s well known that Jeffrey Epstein was a super-wealthy pedophile with an extraordinary network of powerful friends: tech billionaires, politicians and academics. But few people know that he was also a transhumanist — someone who believes that we should...
By Scott Solomon, The MIT Press Reader | 02.12.2026
Chris Mason is a man in a hurry.
“Sometimes walking from the subway to the lab takes too long, so I’ll start running,” he told me over breakfast at a bistro near his home in Brooklyn on a crisp...
By Zachary Brennan, Endpoints News | 02.23.2026
The FDA is spelling out the details of a new pathway to help speed personalized cell and gene therapies to market for rare diseases.
Monday’s long-awaited draft guidance outlines the agency’s “plausible mechanism” framework, a pathway FDA Commissioner Marty Makary...